ATE384700T1 - Tetrahydroisochinolin- und tetrahydrobenzazepin derivative als igf-1r inhibitoren - Google Patents
Tetrahydroisochinolin- und tetrahydrobenzazepin derivative als igf-1r inhibitorenInfo
- Publication number
- ATE384700T1 ATE384700T1 AT04719900T AT04719900T ATE384700T1 AT E384700 T1 ATE384700 T1 AT E384700T1 AT 04719900 T AT04719900 T AT 04719900T AT 04719900 T AT04719900 T AT 04719900T AT E384700 T1 ATE384700 T1 AT E384700T1
- Authority
- AT
- Austria
- Prior art keywords
- tetrahydroisocinoline
- igf
- inhibitors
- tetrahydrobenzazepine derivatives
- tetrahydrobenzazepine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
- C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CH2004/000147 WO2005087743A1 (en) | 2004-03-12 | 2004-03-12 | Tetrahydroisoquinoline-and tetrahydrobenzazepine derivatives as igf-1r inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE384700T1 true ATE384700T1 (de) | 2008-02-15 |
Family
ID=34957074
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04719900T ATE384700T1 (de) | 2004-03-12 | 2004-03-12 | Tetrahydroisochinolin- und tetrahydrobenzazepin derivative als igf-1r inhibitoren |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US7875631B2 (de) |
| EP (1) | EP1732898B1 (de) |
| JP (1) | JP2007528877A (de) |
| CN (1) | CN100590118C (de) |
| AR (1) | AR049323A1 (de) |
| AT (1) | ATE384700T1 (de) |
| AU (1) | AU2004317166B2 (de) |
| BR (1) | BRPI0418462A (de) |
| CA (1) | CA2555745C (de) |
| DE (1) | DE602004011578T2 (de) |
| DK (1) | DK1732898T3 (de) |
| EA (1) | EA200601687A1 (de) |
| ES (1) | ES2299825T3 (de) |
| IL (1) | IL177307A (de) |
| NO (1) | NO20063794L (de) |
| PL (1) | PL1732898T3 (de) |
| PT (1) | PT1732898E (de) |
| SI (1) | SI1732898T1 (de) |
| TW (1) | TW200530213A (de) |
| WO (1) | WO2005087743A1 (de) |
| ZA (1) | ZA200607198B (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090099133A1 (en) * | 2005-09-09 | 2009-04-16 | Jan Gunzinger | Isoquinolines Derivatives as Igf-1R Inhibitors |
| KR20080042897A (ko) * | 2005-09-09 | 2008-05-15 | 아날리테콘에스.에이. | Ｉｇｆ-１ｒ 억제제로서 이소퀴놀린 |
| US8476297B2 (en) | 2007-12-04 | 2013-07-02 | Amgen Inc. | TRP-M8 receptor ligands and their use in treatments |
| JP2013522215A (ja) | 2010-03-09 | 2013-06-13 | オーエスアイ・ファーマシューティカルズ，エルエルシー | 組合わせ抗癌療法 |
| ES2553871T3 (es) | 2010-07-05 | 2015-12-14 | Actelion Pharmaceuticals Ltd. | Derivados heterociclilo 1-fenil-sustituidos y su uso como moduladores del receptor D2 de prostaglandina |
| AU2012212075A1 (en) | 2011-02-02 | 2013-07-18 | Amgen Inc. | Methods and compositons relating to inhibition of IGF-1R |
| JP6268097B2 (ja) | 2011-11-11 | 2018-01-24 | デューク・ユニヴァーシティ | 固形腫瘍治療のための併用薬物療法 |
| RU2014129613A (ru) | 2011-12-21 | 2016-02-10 | Актелион Фармасьютиклз Лтд | Гетероциклильные производные и их применение в качестве модуляторов рецептора простагландина d2 |
| CA2876808A1 (en) | 2012-07-05 | 2014-01-09 | Actelion Pharmaceuticals Ltd | 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators |
| US8980259B2 (en) | 2012-07-20 | 2015-03-17 | Novartis Ag | Combination therapy |
| CN104672136B (zh) * | 2013-11-30 | 2017-01-25 | 沈阳药科大学 | 1‑取代菲基‑n‑烷基(酰基)‑6,7‑二甲氧基‑1,2,3,4‑四氢异喹啉衍生物及其制备方法和用途 |
| WO2017129763A1 (en) | 2016-01-28 | 2017-08-03 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of signet ring cell gastric cancer |
| CN112500345B (zh) * | 2020-12-18 | 2022-06-21 | 西安石油大学 | α-氰基季碳取代四氢异喹啉化合物的合成方法 |
| CN117776987A (zh) * | 2022-09-27 | 2024-03-29 | 苏州阿尔脉生物科技有限公司 | 苯并[7]环烯类衍生物、包含其的药物组合物及其医药用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4349472A (en) * | 1979-04-27 | 1982-09-14 | Schering Corporation | (S)-8(1-Adamantanecarbonyloxy)-7-chloro-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine |
| CA1330560C (en) * | 1986-05-21 | 1994-07-05 | Maurits E. A. Vandewalle | Di- and tetrahydroisoquinoline derivatives |
| WO1990002119A1 (en) * | 1988-08-18 | 1990-03-08 | Banyu Pharmaceutical Co., Ltd. | 1,2,3,4-tetrahydroisoquinoline derivatives |
| US6337338B1 (en) * | 1998-12-15 | 2002-01-08 | Telik, Inc. | Heteroaryl-aryl ureas as IGF-1 receptor antagonists |
| EP1113007A1 (de) * | 1999-12-24 | 2001-07-04 | Pfizer Inc. | Tetrahydroisochinolin-Verbindungen zur Verwendung als Östrogen-Agonisten/-Antagonisten |
| AU2002222853A1 (en) * | 2000-12-07 | 2002-06-18 | Astrazeneca Ab | Therapeutic compounds |
| SE0102168D0 (sv) | 2001-06-19 | 2001-06-19 | Karolinska Innovations Ab | New use and new compounds |
| SE0104140D0 (sv) * | 2001-12-07 | 2001-12-07 | Astrazeneca Ab | Novel Compounds |
| GB0212303D0 (en) | 2002-05-28 | 2002-07-10 | Isis Innovation | Molecular targetting of IGF-1 receptor |
-
2004
- 2004-03-12 WO PCT/CH2004/000147 patent/WO2005087743A1/en active IP Right Grant
- 2004-03-12 DK DK04719900T patent/DK1732898T3/da active
- 2004-03-12 EP EP04719900A patent/EP1732898B1/de not_active Expired - Lifetime
- 2004-03-12 US US10/591,174 patent/US7875631B2/en not_active Expired - Fee Related
- 2004-03-12 PT PT04719900T patent/PT1732898E/pt unknown
- 2004-03-12 PL PL04719900T patent/PL1732898T3/pl unknown
- 2004-03-12 CN CN200480042030A patent/CN100590118C/zh not_active Expired - Fee Related
- 2004-03-12 AT AT04719900T patent/ATE384700T1/de active
- 2004-03-12 AU AU2004317166A patent/AU2004317166B2/en not_active Ceased
- 2004-03-12 JP JP2007502162A patent/JP2007528877A/ja active Pending
- 2004-03-12 ES ES04719900T patent/ES2299825T3/es not_active Expired - Lifetime
- 2004-03-12 BR BRPI0418462-9A patent/BRPI0418462A/pt not_active IP Right Cessation
- 2004-03-12 CA CA2555745A patent/CA2555745C/en not_active Expired - Fee Related
- 2004-03-12 DE DE602004011578T patent/DE602004011578T2/de not_active Expired - Lifetime
- 2004-03-12 SI SI200430684T patent/SI1732898T1/sl unknown
- 2004-03-12 EA EA200601687A patent/EA200601687A1/ru unknown
-
2005
- 2005-02-25 TW TW094105813A patent/TW200530213A/zh unknown
- 2005-03-10 AR ARP050100920A patent/AR049323A1/es not_active Application Discontinuation
-
2006
- 2006-08-06 IL IL177307A patent/IL177307A/en not_active IP Right Cessation
- 2006-08-24 NO NO20063794A patent/NO20063794L/no not_active Application Discontinuation
- 2006-08-29 ZA ZA2006/07198A patent/ZA200607198B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR049323A1 (es) | 2006-07-19 |
| EP1732898A1 (de) | 2006-12-20 |
| EA200601687A1 (ru) | 2007-04-27 |
| US7875631B2 (en) | 2011-01-25 |
| CA2555745A1 (en) | 2005-09-22 |
| CN100590118C (zh) | 2010-02-17 |
| PT1732898E (pt) | 2008-04-07 |
| DE602004011578D1 (de) | 2008-03-13 |
| DK1732898T3 (da) | 2008-05-13 |
| ES2299825T3 (es) | 2008-06-01 |
| PL1732898T3 (pl) | 2008-06-30 |
| NO20063794L (no) | 2006-12-12 |
| DE602004011578T2 (de) | 2009-02-19 |
| AU2004317166B2 (en) | 2010-11-11 |
| CN1922147A (zh) | 2007-02-28 |
| TW200530213A (en) | 2005-09-16 |
| IL177307A0 (en) | 2006-12-10 |
| BRPI0418462A (pt) | 2007-06-05 |
| IL177307A (en) | 2011-09-27 |
| ZA200607198B (en) | 2008-04-30 |
| CA2555745C (en) | 2011-05-31 |
| JP2007528877A (ja) | 2007-10-18 |
| EP1732898B1 (de) | 2008-01-23 |
| AU2004317166A1 (en) | 2005-09-22 |
| US20070129399A1 (en) | 2007-06-07 |
| WO2005087743A1 (en) | 2005-09-22 |
| SI1732898T1 (sl) | 2008-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE400271T1 (de) | Aryl-pyridinderivate als 11-beta-hsd1-hemmer | |
| ATE420076T1 (de) | Indozolonderivate als 11b-hsd1-inhibitoren | |
| ATE540936T1 (de) | Substituierte 2-alkyl-chinazolinonderivate als parp-hemmer | |
| ATE520671T1 (de) | Pyrimidin-harnstoff-derivate als kinase-hemmer | |
| ATE509011T1 (de) | Pyrimidinderivate als 11beta-hsd1-inhibitoren | |
| ATE501138T1 (de) | Thiophenderivate als chk-1-inhibitoren | |
| ATE452631T1 (de) | N-2-adamantanyl-2-phenoxy-acetamid-derivate als 11-betahydroxysteroid-dehydrogenase-hemmer | |
| DE602006011363D1 (de) | Heteroaryl-substituierte piperidin-derivate als l-cpt1-hemmer | |
| ATE423121T1 (de) | Diphenylimidazopyrimidin- und -imidazolamine als b-sekretase-inhibitoren | |
| ZA200610771B (en) | Quinazolinedolone derivatives as PARP inhibitors | |
| ATE527240T1 (de) | Polyzyklische indazol-derivate als erk-hemmer | |
| DE602005025733D1 (de) | Pyrazolopyrimidinderivate als inhibitoren der cyclinabhängigen kinase | |
| ATE404564T1 (de) | Diazepinoindolderivate als kinaseinhibitoren | |
| ATE485268T1 (de) | Pyrrolidin-derivate als erk-hemmer | |
| ATE478064T1 (de) | Als pi-3-kinaseinhibitoren verwendete pyrimidinderivate | |
| ATE530545T1 (de) | Als kinaseinhibitoren geeignete pyrazolylaminopyridinderivate | |
| ATE521607T1 (de) | Piperidinderivate als renin-inhibitoren | |
| ATE394399T1 (de) | Tetrahydropyridoindolderivate | |
| ATE383361T1 (de) | Pyrrazolopyrimidinderivate | |
| ATE540935T1 (de) | Chinazolinderivate | |
| ATE417830T1 (de) | Sulfonylbenzimidazolderivate | |
| IL177307A0 (en) | Tetrahydroisoquinoline-and tetrahydrobenzazepine derivatives as igf-1r inhibitors | |
| ATE430142T1 (de) | Phenylpiperazin-methanon-derivate | |
| ATE404542T1 (de) | 4-phenylpyrimidin-2-carbonitrilderivate | |
| ATE472532T1 (de) | Oxindole als kinaseinhibitoren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1732898 Country of ref document: EP |